Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.6220
-0.0360 (-5.47%)
At close: Oct 30, 2026, 4:00 PM EDT
0.6404
+0.0184 (2.96%)
After-hours: Oct 30, 2026, 7:49 PM EDT
Filana Therapeutics Market Cap
Filana Therapeutics has a market cap or net worth of $30.05 million as of October 30, 2026. It is the 33,832nd most valuable company in the world and the 4,953rd biggest in the United States. Its market cap has decreased by 81.81% in one year.
Market Cap
30.05M
Enterprise Value
-52.63M
1-Year Change
-81.81%
Global Rank
Country Rank
#4,953 United States
Category
ChartMarket Cap Chart
Since July 14, 2000, Filana Therapeutics's market cap has decreased from $565.10M to $30.05M, a decrease of -94.68%. That is a compound annual growth rate of -10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 30.00M | -68.62% |
| Dec 31, 2025 | 95.60M | -15.77% |
| Dec 31, 2024 | 113.50M | -88.04% |
| Dec 29, 2023 | 949.30M | -19.80% |
| Dec 30, 2022 | 1.18B | -32.32% |
| Dec 31, 2021 | 1.75B | 902.69% |
| Dec 31, 2020 | 174.40M | 94.86% |
| Dec 31, 2019 | 89.50M | 513.01% |
| Dec 31, 2018 | 14.60M | -44.70% |
| Dec 29, 2017 | 26.40M | 0.38% |
| Dec 30, 2016 | 26.30M | -67.17% |
| Dec 31, 2015 | 80.10M | -13.78% |
| Dec 31, 2014 | 92.90M | -57.93% |
| Dec 31, 2013 | 220.80M | 80.84% |
| Dec 31, 2012 | 122.10M | -28.01% |
| Dec 30, 2011 | 169.60M | -41.19% |
| Dec 31, 2010 | 288.40M | 27.44% |
| Dec 31, 2009 | 226.30M | -8.97% |
| Dec 31, 2008 | 248.60M | -46.82% |
| Dec 31, 2007 | 467.50M | 18.81% |
| Dec 29, 2006 | 393.50M | 32.67% |
| Dec 30, 2005 | 296.60M | -5.66% |
| Dec 31, 2004 | 314.40M | 28.01% |
| Dec 31, 2003 | 245.60M | 277.85% |
| Dec 31, 2002 | 65.00M | -73.54% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRulya Therapeutics | 33.51M |
| Impact BioMedical | 32.47M |
| EyePoint | 30.04M |
| Aligos Therapeutics | 29.97M |
| Aardvark Therapeutics | 29.76M |
| ProMIS Neurosciences | 29.68M |
| Metagenomi Therapeutics | 29.48M |
| NextCure | 28.88M |